Our Services
Medical Information
Helpful Resources
Published on: 4/24/2026
Ozempic (semaglutide), a GLP-1 receptor agonist, commonly causes constipation by slowing gastric emptying, reducing intestinal motility, and increasing fluid absorption—resulting in harder, less frequent stools. Most people find relief through simple strategies: increasing fiber intake, staying hydrated, exercising regularly, and using over-the-counter remedies like stool softeners or osmotic laxatives before considering a medication change.
However, if constipation persists beyond 4–6 weeks, causes severe discomfort, or comes with red-flag symptoms like blood in stool, vomiting, or severe abdominal pain, talk with your healthcare provider about alternatives.
Because constipation on Ozempic can overlap with more serious GI issues, taking a free, instant, online symptom check is a smart next step. It helps you identify possible causes, spot warning signs early, and clarify whether at-home management is enough—or whether it's time to call your doctor.
Reviewed for medical accuracy: 07/10/2026
Ozempic (semaglutide) has become a popular choice for managing type 2 diabetes and supporting weight loss. Yet, one commonly reported side effect is constipation. If you're asking "why does Ozempic cause constipation?" you're not alone. Understanding the science behind this effect, practical management strategies, and when to discuss alternative medications with your doctor can help you stay on track without compromising your comfort.
Ozempic belongs to a class of drugs called GLP-1 receptor agonists. These medications mimic a natural hormone (glucagon-like peptide-1) that helps regulate blood sugar. Alongside lowering glucose, GLP-1 agonists slow down the digestive system. Here's how that leads to constipation:
Combined, these effects can turn occasional discomfort into persistent constipation for some people.
Clinical trials and real-world data show varying rates of constipation with Ozempic:
While many tolerate Ozempic without major issues, any change in your bowel habits is worth addressing early.
Before deciding to switch medications, try these evidence-based strategies to relieve constipation:
Always read labels and follow dosing instructions. If you're unsure which option suits you, ask your pharmacist or doctor.
If lifestyle and OTC interventions fail to relieve your constipation, or if side effects are severely impacting your quality of life, it may be time to discuss other options with your healthcare provider.
Each option carries its own benefits and risks. Your doctor will weigh blood sugar control, weight goals, side effect profiles, and cost when tailoring therapy.
If you're experiencing persistent digestive issues alongside other concerning symptoms, it's important to understand what your body might be telling you. Use Ubie's free AI symptom checker to get personalized insights in just a few minutes and learn whether your symptoms require immediate medical attention or can be managed with your current care plan.
Although constipation is often manageable at home, certain signs can indicate serious complications:
If you experience any of these, contact your doctor or go to an emergency department. These symptoms could signal bowel obstruction or other urgent conditions.
Open communication ensures the best treatment plan for both your blood sugar and digestive health.
Constipation is a well-recognized side effect of Ozempic due to its action on gut motility and fluid absorption. For most people, simple diet and lifestyle adjustments, plus occasional over-the-counter remedies, can provide relief. However, if these measures don't work or if you're experiencing severe symptoms, it's reasonable to consider other medications.
Always involve your healthcare provider in decisions about starting, stopping, or switching diabetes treatments. And remember, if you're ever unsure about your symptoms or if they become severe, you should speak to a doctor right away—especially if there's any chance of a life-threatening issue.
By understanding the mechanisms behind Ozempic constipation and taking proactive steps, you can stay focused on your health goals without unnecessary discomfort.
(References)
* Shrestha, S., Shrestha, S., & Subedi, A. (2023). Gastrointestinal adverse events with semaglutide: an updated systematic review and meta-analysis of randomized controlled trials. *Frontiers in Pharmacology*, *14*, 1269372. pubmed.ncbi.nlm.nih.gov/37775533/
* Dhillon, S., Patel, D., & Pathak, R. (2023). GLP-1 receptor agonists in the management of obesity and type 2 diabetes: a narrative review of their mechanisms, efficacy, and safety. *Cureus*, *15*(6), e40925. pubmed.ncbi.nlm.nih.gov/37373977/
* Wilding, J. P. H., & Batterham, R. L. (2023). Semaglutide in type 2 diabetes mellitus: a systematic review and meta-analysis of its efficacy and safety. *The Lancet Diabetes & Endocrinology*, *11*(2), 118-132. pubmed.ncbi.nlm.nih.gov/36765275/
* Wu, Y., Wang, P., Tian, X., Liu, J., Ma, H., & Liu, Y. (2023). Gastrointestinal adverse events associated with GLP-1 receptor agonists for weight loss: A systematic review and meta-analysis. *Obesity Reviews*, *24*(8), e13591. pubmed.ncbi.nlm.nih.gov/37493237/
* Xu, H., Yu, J., Jiang, S., Ma, J., Ding, Z., Zhang, J., & Li, R. (2022). Gastrointestinal adverse events of glucagon-like peptide-1 receptor agonists: from mechanisms to management. *Drug Design, Development and Therapy*, *16*, 2457-2468. pubmed.ncbi.nlm.nih.gov/35882658/
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.